Covered recipient · General Payments record
WALTER CHMELEWSKI
General Payments · PY2019–2025
$4,170.31
- Reported across 230 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,081.53 | 52 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $298.40 | 18 |
| ABBVIE INC. | $177.56 | 13 |
| BOSTON SCIENTIFIC CORPORATION | $111.42 | 2 |
| ASD SPECIALTY HEALTHCARE, LLC | $110.73 | 1 |
| Radius Health, Inc. | $58.99 | 2 |
| Novo Nordisk AS | $57.04 | 3 |
| UCB, Inc. | $50.58 | 2 |
| Abbott Laboratories | $29.57 | 1 |
| Lilly USA, LLC | $29.50 | 2 |
| PFIZER INC. | $25.99 | 1 |
| Seqirus USA Inc | $24.81 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.90 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.62 | 1 |
| Grifols USA, LLC | $18.28 | 1 |
| GENZYME CORPORATION | $18.12 | 1 |
| Merck Sharp & Dohme Corporation | $16.02 | 1 |
| Daiichi Sankyo Inc. | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (52)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $29.57 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1239968749 | CMS |
| ABBVIE INC. | $16.86 | 02/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654160 | CMS |
| ABBVIE INC. | $28.15 | 04/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654162 | CMS |
| ABBVIE INC. | $9.18 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654164 | CMS |
| ABBVIE INC. | $5.27 | 05/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654166 | CMS |
| ABBVIE INC. | $22.67 | 05/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654168 | CMS |
| ABBVIE INC. | $24.77 | 06/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654170 | CMS |
| ABBVIE INC. | $4.69 | 07/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654172 | CMS |
| ABBVIE INC. | $2.30 | 07/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654174 | CMS |
| ABBVIE INC. | $23.82 | 07/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654176 | CMS |
| ABBVIE INC. | $5.56 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654178 | CMS |
| ABBVIE INC. | $11.36 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654180 | CMS |
| ABBVIE INC. | $17.23 | 11/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654182 | CMS |
| ABBVIE INC. | $5.70 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201654184 | CMS |
| Amgen Inc. | $6.88 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102716 | CMS |
| Amgen Inc. | $13.12 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102718 | CMS |
| Amgen Inc. | $125.00 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228515634 | CMS |
| Amgen Inc. | $7.30 | 04/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102734 | CMS |
| Amgen Inc. | $0.66 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102730 | CMS |
| Amgen Inc. | $12.85 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102732 | CMS |
| Amgen Inc. | $12.57 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102736 | CMS |
| Amgen Inc. | $1.73 | 07/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102726 | CMS |
| Amgen Inc. | $9.37 | 07/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102720 | CMS |
| Amgen Inc. | $15.61 | 08/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228515632 | CMS |
| Amgen Inc. | $9.25 | 09/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102722 | CMS |
| Amgen Inc. | $8.79 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102724 | CMS |
| Amgen Inc. | $19.61 | 10/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228515630 | CMS |
| Amgen Inc. | $7.10 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102728 | CMS |
| Amgen Inc. | $13.45 | 10/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102712 | CMS |
| Amgen Inc. | $9.98 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102708 | CMS |
| Amgen Inc. | $13.86 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102714 | CMS |
| Amgen Inc. | $11.27 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102710 | CMS |
| ASD Specialty Healthcare, LLC | $110.73 | 02/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1253237491 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.62 | 02/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222810431 | CMS |
| Boston Scientific Corporation | $56.06 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181565345 | CMS |
| Boston Scientific Corporation | $55.36 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181565347 | CMS |
| Daiichi Sankyo Inc. | $15.00 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197070911 | CMS |
| GENZYME CORPORATION | $18.12 | 12/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233696659 | CMS |
| Grifols USA, LLC | $18.28 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249572143 | CMS |
| Lilly USA, LLC | $13.70 | 01/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186957157 | CMS |
| Lilly USA, LLC | $15.80 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187005428 | CMS |
| Merck Sharp & Dohme LLC | $16.02 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238175199 | CMS |
| Novartis Pharmaceuticals Corporation | $19.90 | 07/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200176284 | CMS |
| Novo Nordisk Inc | $16.96 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190291601 | CMS |
| Novo Nordisk Inc | $19.33 | 02/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190289427 | CMS |
| Novo Nordisk Inc | $20.75 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1192976855 | CMS |
| PFIZER INC. | $25.99 | 03/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229091987 | CMS |
| Radius Health, Inc. | $26.04 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249526226 | CMS |
| Radius Health, Inc. | $32.95 | 11/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249526228 | CMS |
| Seqirus USA Inc | $24.81 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201098227 | CMS |
| UCB, Inc. | $23.43 | 07/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224746185 | CMS |
| UCB, Inc. | $27.15 | 10/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224746187 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.